International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. (2016)
Attributed to:
Overcoming immunological barriers to regenerative medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jcyt.2015.11.008
PubMed Identifier: 26724220
Publication URI: http://europepmc.org/abstract/MED/26724220
Type: Journal Article/Review
Volume: 18
Parent Publication: Cytotherapy
Issue: 2
ISSN: 1465-3249